Real-world Cohort of Patients with Diabetic Macular Oedema from 4 UK National Health Service Treatment Centres

被引：0
|
作者：
Peto, T. [1 ]
Ghanchi, F. [2 ,3 ]
Talks, S. J. [4 ]
Menon, G. [5 ,6 ]
Chen, X. [7 ]
Chin, G. [7 ]
机构：
[1] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland
[2] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England
[3] Bradford Ophthalmol Res Network, Bradford, W Yorkshire, England
[4] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[5] Frimley Hlth NHS Fdn Trust, Frimley, England
[6] NIHR Kent Surrey Sussex Clin Res Network, Frimley, England
[7] Genentech Inc, South San Francisco, CA USA
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2022年 / 32卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [1] Real-world outcomes of Ranibizumab treatment for Diabetic Macular Oedema
    Patrao, Namritha Valerie
    Antao, Sheelah
    Sim, Dawn A.
    Sivaprasad, Sobha
    Andrews, Richard
    Hamilton, Robin
    Egan, Catherine A.
    Tufail, Adnan
    Hykin, Philip G.
    Rajendram, Ranjan
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [2] Clinical real-world results of switching treatment from ranibizumab to aflibercept in patients with diabetic macular oedema
    V E Konidaris
    K T Tsaousis
    Z Al-Hubeshy
    K Pieri
    J Deane
    T Empeslidis
    [J]. Eye, 2017, 31 : 1629 - 1630
  • [3] Clinical real-world results of switching treatment from ranibizumab to aflibercept in patients with diabetic macular oedema
    Konidaris, V. E.
    Tsaousis, K. T.
    Al-Hubeshy, Z.
    Pieri, K.
    Deane, J.
    Empeslidis, T.
    [J]. EYE, 2017, 31 (11) : 1629 - 1630
  • [4] Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting
    Patrao, Namritha V.
    Antao, Sheelah
    Egan, Catherine
    Omar, Amer
    Hamilton, Robin
    Hykin, Philip G.
    Sivaprasad, Sobha
    Rajendram, Ranjan
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 172 : 51 - 57
  • [5] Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting
    Calugaru, Dan
    Calugaru, Mihai
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 174 : 175 - 176
  • [6] Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting REPLY
    Patrao, Namritha V.
    Antao, Sheelah
    Egan, Catherine
    Omar, Amer
    Hamilton, Robin
    Hykin, Philip G.
    Sivaprasad, Sobha
    Rajendram, Ranjan
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 174 : 176 - 176
  • [7] A real-world study of the effectiveness of DBT in the UK National Health Service
    Feigenbaum, Janet D.
    Fonagy, Peter
    Pilling, Stephen
    Jones, Alan
    Wildgoose, Amanda
    Bebbington, Paul E.
    [J]. BRITISH JOURNAL OF CLINICAL PSYCHOLOGY, 2012, 51 : 121 - 141
  • [8] Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes
    Sivaprasad, Sobha
    Ghanchi, Faruque
    Kelly, Simon P.
    Kotagiri, Ajay
    Talks, James
    Scanlon, Peter
    McGoey, Hellen
    Nolan, Andrew
    Saddiq, Moneeb
    Napier, Jackie
    [J]. EYE, 2023, 37 (13) : 2753 - 2760
  • [9] Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes
    Sobha Sivaprasad
    Faruque Ghanchi
    Simon P. Kelly
    Ajay Kotagiri
    James Talks
    Peter Scanlon
    Hellen McGoey
    Andrew Nolan
    Moneeb Saddiq
    Jackie Napier
    [J]. Eye, 2023, 37 : 2753 - 2760
  • [10] Real-world treatment of diabetic macular oedema: a comparison of combined ranibizumab plus macular LASER with macular LASER monotherapy
    Zygoura, Vasiliki
    Papavasileiou, Evangelia
    Vavvas, Demetrios G.
    Cortis, Dominic
    Eleftheriadis, Haralabos
    Jackson, Timothy L.
    [J]. HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2015, 18 (03): : 33 - 41
12345